A vault nanoparticle vaccine induces protective mucosal immunity.
Generation of robust cell-mediated immune responses at mucosal surfaces while reducing overall inflammation is a primary goal for vaccination. Here we report the use of a recombinant nanoparticle as a vaccine delivery platform against mucosal infections requiring T cell-mediated immunity for eradica...
Main Authors: | Cheryl I Champion, Valerie A Kickhoefer, Guangchao Liu, Raymond J Moniz, Amanda S Freed, Liisa L Bergmann, Dana Vaccari, Sujna Raval-Fernandes, Ann M Chan, Leonard H Rome, Kathleen A Kelly |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2671841?pdf=render |
Similar Items
-
A Protective Vaccine against Chlamydia Genital Infection Using Vault Nanoparticles without an Added Adjuvant
by: Janina Jiang, et al.
Published: (2017-01-01) -
Draft crystal structure of the vault shell at 9-A resolution.
by: Daniel H Anderson, et al.
Published: (2007-11-01) -
Vault nanocapsules as adjuvants favor cell-mediated over antibody-mediated immune responses following immunization of mice.
by: Upendra K Kar, et al.
Published: (2012-01-01) -
The TROVE module: A common element in Telomerase, Ro and Vault ribonucleoproteins
by: Bateman Alex, et al.
Published: (2003-10-01) -
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth.
by: Upendra K Kar, et al.
Published: (2011-05-01)